ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Disease
Lung Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Respiratory Tract Diseases

Asthma trials near Cincinnati, OH, USA:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Cincinnati, Ohio, United States and 43 other locations

This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....

Active, not recruiting
Asthma
Drug: Placebo
Drug: Dupilumab

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Cincinnati, Ohio, United States and 7 other locations

The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...

Enrolling
Severe Asthma
Drug: GB-0895
Drug: Placebo

Phase 3

Generate Biomedicines

Dayton, Ohio, United States and 94 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Cincinnati, Ohio, United States and 335 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Cincinnati, Ohio, United States and 146 other locations

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...

Active, not recruiting
Asthma
Biological: NSI-8226
Biological: Placebo

Phase 2

Uniquity One (UNI)

Dayton, Ohio, United States and 70 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Cincinnati, Ohio, United States and 134 other locations

trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...

Active, not recruiting
Asthma
Drug: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
Drug: Inhaled corticosteroids/long-acting beta-2 agonists

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Cincinnati, Ohio, United States and 116 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Invitation-only
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Cincinnati, Ohio, United States and 74 other locations

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...

Active, not recruiting
Asthma
Drug: dupilumab
Drug: Matching Placebo

Phase 4

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Cincinnati, Ohio, United States and 77 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems